Addressing Challenges in Detecting New Drugs: Instrumentation for Alternative Analytical Methods (R43/R44 - Clinical Trials Optional)

Emerging threats continuously evolve.

Xylazine, nitazenes, and other future threats are making their way or are already in the drug supply.

Understanding them requires analyzing real world samples.

Typically, testing strips are used to detect drug for which such strip exists, as


the strips are fast, sensitive, low cost and reasonably accurate.

However, as there might not be testing strips for the new threats, the analysis must be performed via sensitive and sample agnostic methods.
Related Programs

Drug Abuse and Addiction Research Programs

Department of Health and Human Services


Agency: Department of Health and Human Services

Office: National Institutes of Health

Estimated Funding: $6,000,000


Who's Eligible





Obtain Full Opportunity Text:
https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-26-018.html

Additional Information of Eligibility:
Other Eligible Applicants include the following: See NOFO for further eligibility details.

Full Opportunity Web Address:
http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-26-018.html

Contact:


Agency Email Description:
See Section VII. Agency Contacts within the full opportunity announcement for all other inquires.

Agency Email:


Date Posted:
2024-11-04

Application Due Date:


Archive Date:
2025-03-27



Social Entrepreneurship
Spotlight



Digbeth: The New Social Enterprise Quarter


Digbeth in Birmingham, England has been appointed as the new social enterprise quarter. Social enterprises are sprouting up in the area, comprising of 57 of these businesses flanked between High Gate and Hurst Street.






More Federal Domestic Assistance Programs


Choice Neighborhoods | Suisun Marsh Preservation Agreement | Impact Aid | Mortgage Insurance_Single Family Cooperative Housing | RECOVERY ACT VOCA CRIME VICTIM ASSISTANCE DISCRETIONARY GRANT PROGRAM |  Site Style by YAML | Grants.gov | Grants | Grants News | Sitemap | Privacy Policy


Edited by: Michael Saunders

© 2004-2024 Copyright Michael Saunders